Three Indian companies are among the 21 firms that have got the licences from United States' National Aeronautics and Space Administration (NASA) to manufacture the ventilators developed by the space agency’s Jet Propulsion Laboratory (JPL) for treatment of COVID-19 patients, reports Times of India.
The three Indian companies that got NASA’s approval are Alpha Design Technologies Private Limited, Bharat Forge Limited, and Medha Servo Drives Private Limited.
Besides, eight companies from the United States, three from Brazil, and one each from Australia, Canada, Egypt, Malaysia, Mexico, Turkey, and the United Arab Emirates have also been approved by NASA to manufacture the ventilators.
The prototype, which was created by JPL engineers in just 37 days, received an Emergency Use Authorization from the Food and Drug Administration on 30 April, NASA said in a release on Friday (29 May).
Called VITAL (Ventilator Intervention Technology Accessible Locally), the high-pressure ventilator was designed to use one-seventh the parts of a traditional ventilator, relying on parts already available in supply chains, NASA said.
It offers a simpler, more affordable option for treating critical patients while freeing up traditional ventilators for those with the most severe COVID-19 symptoms. Its flexible design means it also can be modified for use in field hospitals.
Comments ↓
An Appeal...
Dear Reader,
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.